Kate Broderick

Chief Scientific & Innovation Officer Artis BioSolutions

Seminars

Thursday 12th November 2026
Better mRNA Starts With Better DNA: Rethinking the IVT Template
11:50 am
  • Discover why mRNA developers are moving from plasmid DNA to cell-free synthetic DNA
  • Unveil how structure-guided adapter design improves T7 transcription, higher mRNA yield and lower dsRNA
  • Discuss what a faster, integrated path from sequence to LNP:mRNA drug product looks like
Kate Broderick